← Eichor
Study identifier: NCT07304401 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Evaluation of Effectiveness of Closed-loop Spinal Cord Stimulation (CL-SCS) Therapy for Treatment of Chemotherapy Induced Peripheral Neuropathy

Condition: Chemotherapy Induced Peripheral Neuropathy (CIPN) · Neuropathic Pain  ·  Sponsor: Rijnstate Hospital

PhaseN/A
Planned participants20
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this observational study is to learn about the effectiveness of closed-loop spinal cord stimulation (CL-SCS) therapy for treatment of painful chemotherapy induced peripheral neuropathy. The closed-loop SCS (CL-SCS) system stimulates the nerves in the spinal cord, measures their responses and automatically adjust the stimulation level accordingly in real time for each delivered pulse.

This description comes directly from the study's public registry record.

Talk to the study team

Esmee Van Leeuwen, MSc  ·  088 005 8888  ·  evanleeuwen@rijnstate.nl

Nick Koning, MD PhD

Always discuss trial participation with your own doctor first.

Locations (5)

Rijnstate HospitalArnhem, NetherlandsRecruiting
Sint Antonius ZiekenhuisNieuwegein, NetherlandsRecruiting
Bravis HospitalRoosendaal, NetherlandsRecruiting
ETZTilburg, NetherlandsRecruiting
ASZZwijndrecht, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07304401